The Swedish RAND-36 Health Survey - reliability and responsiveness assessed in patient populations using Svensson's method for paired ordinal data.
Lotti Orwelius, Mats Nilsson, Evalill Nilsson...
https://pubmed.ncbi.nlm.nih.gov/29757320/Actively Recruiting
Led by Karolinska University Hospital · Updated on 2026-10-08
282
Participants Needed
2
Research Sites
143 weeks
Total Duration
Researchers are evaluating treatment strategies for people aged 78 years and older with symptomatic atrial fibrillation AF, a common heart rhythm disorder that can reduce quality of life and cause serious complications like stroke and heart failure. This multicenter, randomized study compares catheter ablation, an invasive procedure targeting heart triggers, to optimized medical therapy without ablation. The study aims to understand which approach better benefits very elderly patients with AF. Participants are randomly assigned to one of two groups catheter ablation with pulmonary vein isolation as the main procedure, or optimized medical therapy including rate and rhythm control medications, with AV node ablation and pacemaker implantation allowed if clinically needed. All participants receive an implantable loop recorder implanted under the skin to continuously monitor heart rhythm and measure AF burden throughout the study. Treatment and follow-up are performed according to local clinical practice and study protocols. During the study, participants undergo initial screening, baseline assessments, and implantation of the loop recorder. Follow-up visits occur at about 3, 12, 18, and 24 months after randomization, with continuous heart rhythm monitoring throughout. Researchers collect data on clinical events, treatment changes, adverse events, and patient-reported quality of life measures. The main outcomes include a composite of major clinical events and changes in health-related quality of life over 24 months. Safety is carefully monitored by an independent committee, and additional exploratory assessments and subgroup analyses are planned.
CONDITIONS
Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation
E
Emmanouil Charitakis, MD, PhD
N
Nikola Drca, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Karolinska University Hospital
Lead Sponsor
University Hospital, Linkoeping
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and baseline visit
Duration - Up to 1 month
Participants receive an implantable loop recorder and are randomly assigned to either catheter ablation or optimized medical therapy.
1 visit for implantation and randomization
Duration - 24 months
Participants receive assigned treatment with continuous heart rhythm monitoring via the loop recorder. Treatment follows clinical guidelines and local standards.
Follow-up visits at approximately 3, 12, 18, and 24 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Lotti Orwelius, Mats Nilsson, Evalill Nilsson...
https://pubmed.ncbi.nlm.nih.gov/29757320/Moonki Jung, Pil-Sung Yang, Daehoon Kim...
https://pubmed.ncbi.nlm.nih.gov/38000669/Stylianos Tzeis, Edward P Gerstenfeld, Jonathan Kalman...
https://pubmed.ncbi.nlm.nih.gov/38597857/Ricarda Marinigh, Gregory Y H Lip, Nicola Fiotti...
https://pubmed.ncbi.nlm.nih.gov/20813280/Isabelle C Van Gelder, Michiel Rienstra, Karina V Bunting...
https://pubmed.ncbi.nlm.nih.gov/39210723/Carina Blomström-Lundqvist, Sigfus Gizurarson, Jonas Schwieler...
https://pubmed.ncbi.nlm.nih.gov/30874754/L Friberg, L Bergfeldt
https://pubmed.ncbi.nlm.nih.gov/23879838/Douglas L Packer, Daniel B Mark, Richard A Robb...
https://pubmed.ncbi.nlm.nih.gov/30874766/Shu Hirata, Yasuo Okumura, Koichi Nagashima...
https://pubmed.ncbi.nlm.nih.gov/41288543/Finn Akerström, Julie Hutter, Emmanouil Charitakis...
https://pubmed.ncbi.nlm.nih.gov/37657914/Karolinska University Hospital
Lead Sponsor
University Hospital, Linkoeping
Collaborating Sponsor